Royal Bank of Canada
ETON icon

Royal Bank of Canada’s Eton Pharmaceutcials ETON Stock Holding History

Royal Bank of Canada’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29K Buy
811
+798
+6,138% +$23.4K ﹤0.01% 6098
2026
Q1 		$0 Sell
13
-1,005
-99% -$17.6K ﹤0.01% 7277
2025
Q4 		$17K Sell
1,018
-478,175
-100% -$8.41M ﹤0.01% 6134
2025
Q3 		$10.4M Buy
479,193
+474,128
+9,361% +$7.87M ﹤0.01% 2125
2025
Q2 		$72K Buy
5,065
+3,436
+211% +$54.3K ﹤0.01% 5760
2025
Q1 		$22K Buy
1,629
+877
+117% +$13.3K ﹤0.01% 5877
2024
Q4 		$10K Buy
752
+477
+173% +$4.84K ﹤0.01% 6343
2024
Q3 		$2K Sell
275
-472
-63% -$2K ﹤0.01% 6637
2024
Q2 		$2K Sell
747
-18
-2% -$63 ﹤0.01% 6721
2024
Q1 		$3K Sell
765
-1,866
-71% -$8.15K ﹤0.01% 6588
2023
Q4 		$12K Buy
+2,631
New +$10.5K ﹤0.01% 6448
2023
Q3 		– Sell
-4,881
Closed -$17K – 7208
2023
Q2 		$17K Buy
4,881
+4,511
+1,219% +$16.6K ﹤0.01% 6281
2023
Q1 		$1K Buy
+370
New +$1.35K ﹤0.01% 6882
2022
Q4 		– Sell
-49
Closed – – 7354
2022
Q3 		$0 Buy
+49
New +$122 ﹤0.01% 7551
2022
Q2 		– Sell
-23
Closed – – 7460
2022
Q1 		$0 Buy
+23
New +$90 ﹤0.01% 7810
2021
Q4 		– Sell
-1,000
Closed -$5K – 7723
2021
Q3 		$5K Sell
1,000
-2,113
-68% -$11K ﹤0.01% 7128
2021
Q2 		$19K Sell
3,113
-57,308
-95% -$425K ﹤0.01% 6585
2021
Q1 		$443K Buy
60,421
+334
+0.6% +$2.85K ﹤0.01% 4292
2020
Q4 		$488K Buy
60,087
+828
+1% +$6.39K ﹤0.01% 4156
2020
Q3 		$469K Sell
59,259
-988
-2% -$6.75K ﹤0.01% 3914
2020
Q2 		$328K Sell
60,247
-5,002
-8% -$24.8K ﹤0.01% 4095
2020
Q1 		$268K Buy
65,249
+1,032
+2% +$6.02K ﹤0.01% 4118
2019
Q4 		$462K Buy
64,217
+63,111
+5,706% +$390K ﹤0.01% 4045
2019
Q3 		$7K Buy
+1,106
New +$7.06K ﹤0.01% 5890

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Royal Bank of Canada's ETON Position: Q2 2026 in Review

Royal Bank of Canada increased its Eton Pharmaceutcials (ETON) stake by 6,138% in Q2 2026, buying an estimated $23.4K and bringing the position to 811 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #6098.

Royal Bank of Canada first reported a position in ETON in Q3 2019 and has held it in 24 quarters since. The position peaked at $10.4M in Q3 2025. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Royal Bank of Canada held 811 shares of Eton Pharmaceutcials worth $29K as of Q2 2026.
  • Royal Bank of Canada bought 798 Eton Pharmaceutcials shares in Q2 2026, an estimated $23.4K.
  • Eton Pharmaceutcials made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #6098 holding.
  • Royal Bank of Canada first reported a position in Eton Pharmaceutcials in Q3 2019 and has held it in 24 quarters since.
  • Royal Bank of Canada's Eton Pharmaceutcials position peaked at $10.4M in Q3 2025.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.